Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company. The agreement is effective starting August 1, 2022.
Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for more than 50% of the nation’s acute care providers. This includes 97% of the nation’s academic medical centers, and more than 20% of ambulatory care providers. Vizient provides expertise, analytics, and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume to improve patient outcomes and lower costs.
This new agreement allows Vizient members to take advantage of special pricing and terms pre-negotiated by Vizient for Central Venous Access products.
